Compare Pikko Land Development Tbk. (RODA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pikko Land Development Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pikko Land Development Tbk. trades at Rp65 (market cap 924.26B, 25.34M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pikko Land Development Tbk. is far larger — about 8.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RODA | SCPI | |
|---|---|---|
Market Cap | 924.26B | 104.4B |
Volume | 25.34M | — |
Lot | 253.36K | — |
Turnover | 1.63B | — |
Average Price | 64.29 | — |
Value | 1.63B | — |
Indicative Equilibrium Price | 65 | — |
Indicative Equilibrium Volume | 3.17K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pikko Land Development Tbk.
PT Pikko Land Development Tbk (formerly PT Royal Oak Development Asia) was established called PT Roda Panggon Harapan based on notarial deed No.83 dated October 15, 1984 of Benny Kristianto, S.H., a public notary in Jakarta. The Company business is in property development, where most of its project located around Jakarta & Tanggerang. One of the biggest project is Simprug Estate in Poris, Tanggerang.
Read more on RODA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
